Skip to main content

Table 5 The overlap between CA125-positive samples (cut-off > 35 IU/mL) and the three DNAme marker panel (defined in Table 1) in cases and controls in the UKCTOCS “low DNA” nested case/control setting

From: The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer

  Controls (CA125) Cases (CA125)
Negative Positive Negative Positive
3 DNAme marker panel Negative 56 3 4 4
Positive 8 0 7 4